| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/22/2007 | EP1819736A2 Use of endosialin binding proteins to isolate endosialin positive cells |
| 08/22/2007 | EP1819735A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 08/22/2007 | EP1819734A2 Antibodies binding to cd34+/cd36+ fetal but not to adult cells |
| 08/22/2007 | EP1819733A1 Monoclonal antibody to human tgf-beta induced gene-h3 and use thereof |
| 08/22/2007 | EP1819732A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/22/2007 | EP1819731A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 08/22/2007 | EP1819730A2 Method of producing antibodies |
| 08/22/2007 | EP1819728A2 Il-7 variants with reduced immunogenicity |
| 08/22/2007 | EP1819726A1 Modulation of ovulation |
| 08/22/2007 | EP1819722A1 Modulation of ovulation |
| 08/22/2007 | EP1819359A2 Anti-integrin immunoconjugates, methods and uses |
| 08/22/2007 | EP1819358A2 Antibodies against vascular endothelial growth factor receptor-1 |
| 08/22/2007 | EP1819346A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 08/22/2007 | EP1660654A4 Expression vector |
| 08/22/2007 | EP1620549B1 Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1242446B1 Immunoenzymatic quantification method |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | EP0956353B1 Manipulation of cellulose. |
| 08/22/2007 | EP0933423B1 Meltrins |
| 08/22/2007 | CN1333077C Cascade expression of active fragment of cholecystokinin and application thereof |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN101023172A Method of producing glycoprotein composition |
| 08/22/2007 | CN101023164A Cancerous disease modifying antibodies |
| 08/22/2007 | CN101023102A Anti-OX40L antibodies |
| 08/22/2007 | CN101023101A Anti-rhesus D recombinant polyclonal antibody and methods of manufacture |
| 08/22/2007 | CN101023100A Her2抗体组合物 Her2 antibody composition |
| 08/22/2007 | CN101023099A Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 08/22/2007 | CN101023098A Method of detecting hepatitis B virus s antigen |
| 08/22/2007 | CN101023095A Genetic engineering protein P40 and appliance thereof |
| 08/22/2007 | CN101022831A Stabilizing formulations |
| 08/22/2007 | CN101022830A Ligands binding the complex of urokinase-type plasminogen activator(uPA) and its receptor(uPAR) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 08/22/2007 | CN101020717A Specific antibody of humphead snapper and its prepn process |
| 08/22/2007 | CN101020716A Prepn and application of human tumor relevant N-jointing glycosyl chain monoclonal antibody |
| 08/21/2007 | USRE39792 Method for culturing Chinese hamster ovary cells |
| 08/21/2007 | US7259296 Method for modifying plant morphology, biochemistry and physiology |
| 08/21/2007 | US7259253 Comprises nucleotide sequences coding protein-608 and/or adlican-2 polypeptides for diagnosis, prevention and treatment of osteoporosis and/or bone disorders |
| 08/21/2007 | US7259249 Method for preparing conjugates of proteins and chelating agents |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259246 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 08/21/2007 | US7259245 For diagnosis of cell proliferation/differentiation disorders of hedgehog (Hh) cascade signaling sequences |
| 08/21/2007 | US7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same |
| 08/21/2007 | US7259243 Process for isolation of osteopontin from milk |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity. |
| 08/21/2007 | US7259146 Stimulate hematopoiesis; administering peptide |
| 08/21/2007 | US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 08/21/2007 | US7259022 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/21/2007 | US7258991 Antibody to bladder cancer nuclear matrix protein and its use |
| 08/21/2007 | US7258989 Carbohydrate deficient transferrin (CDT) -specific antibodies, their preparation and use |
| 08/21/2007 | US7258988 Comprises endothelial cell protein for diagnosing hemostatic, cardiovascular, thrombotic, inflammatory, bone and urogenital disorder |
| 08/21/2007 | US7258986 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 08/21/2007 | US7258983 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 08/21/2007 | US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer |
| 08/21/2007 | US7258860 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/21/2007 | US7258859 Method for the treatment of multiple sclerosis |
| 08/21/2007 | US7258857 Rage-related methods for treating inflammation |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/21/2007 | CA2247966C Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof |
| 08/21/2007 | CA2178517C Neisseria meningitidis capsular polysaccharide conjugates |
| 08/21/2007 | CA2070004C Cloned glutamic acid decarboxylase |
| 08/16/2007 | WO2007092939A2 Antigenic gm-csf peptides and antibodies to gm-csf |
| 08/16/2007 | WO2007092023A1 Compositions and methods for binding or inactivating ghrelin |
| 08/16/2007 | WO2007090872A2 Antibodies against secreted fri zzled related protein-4 (sfrp-4 ) |
| 08/16/2007 | WO2007090862A2 Neutral sphingomyelinase-3 and its use |
| 08/16/2007 | WO2007090807A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | WO2007090675A2 Novel oxidoreductases and uses thereof |
| 08/16/2007 | WO2007090294A1 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment |
| 08/16/2007 | WO2007090280A1 Method for differentiating between multiple sclerosis subtypes |
| 08/16/2007 | WO2007067627A3 Isolating prions from blood via lipoproteins |
| 08/16/2007 | WO2007047112A3 Anti-myostatin antibodies |
| 08/16/2007 | WO2007044411A3 Anti-myostatin antibodies |
| 08/16/2007 | WO2007027954A3 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
| 08/16/2007 | WO2007013670A3 Gene galnt6 as breast cancer marker and small interfering rnas directed against gene galnt6 |
| 08/16/2007 | WO2005106010A3 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 08/16/2007 | WO2005047860A3 Antibodies to alpha-synuclein |
| 08/16/2007 | WO2005012489A3 Targeting endothelium for tissue-specific delivery of agents |
| 08/16/2007 | WO2004064763A3 Cleavage of serum response factor in cardiac diagnosis and therapy |
| 08/16/2007 | WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 08/16/2007 | WO2004000997A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/16/2007 | WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/16/2007 | WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 08/16/2007 | WO2000000156A3 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands |
| 08/16/2007 | US20070192887 TAT-042 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192885 TAT-039 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192884 TAT-038 and methods of assessing and treating cancer |
| 08/16/2007 | US20070192883 TAT-028 and methods of assessing and treating cancer |
| 08/16/2007 | US20070191594 Using hydrophobic charge induction chromatography to isolate preferential immunoglobulins in mixture |
| 08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
| 08/16/2007 | US20070191295 Gene silencing by systemic rna interference |
| 08/16/2007 | US20070191270 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/16/2007 | US20070190615 Use of a gene coding for the C4BP protein beta chain for producing recombinant dimeric proteins |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190599 Anti-glypican 3 antibody |
| 08/16/2007 | US20070190598 Method of reducing leachate from protein a affinity media |
| 08/16/2007 | US20070190597 Oligosaccharide modification and labeling of proteins |
| 08/16/2007 | US20070190581 Density enhanced protein tyrosine phosphatases |
| 08/16/2007 | US20070190577 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 08/16/2007 | US20070190576 Mitogenic oxygenase regulators |